Edition:
United Kingdom

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

1.50USD
18 Jun 2018
Change (% chg)

-- (--)
Prev Close
$1.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,049
52-wk High
$2.95
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Chiasma Announces Expected Year-End 2017 Cash And Investments Balance Of About $67 Mln
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Chiasma Inc ::CHIASMA INC - ANNOUNCES EXPECTED YEAR-END 2017 CASH AND INVESTMENTS BALANCE OF APPROXIMATELY $67 MILLION.CHIASMA-EXISTING CASH TO BE SUFFICIENT TO FUND OPERATIONS THROUGH ANTICIPATED RELEASE OF TOP-LINE DATA FROM CHIASMA OPTIMAL PHASE 3 TRIAL BY 2019 END.  Full Article

Chiasma Q3 loss per share $0.28
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Chiasma Inc ::Chiasma reports third quarter 2017 results.Q3 loss per share $0.28.Chiasma Inc - ‍ cash, cash equivalents & marketable securities as of Sept 30, 2017 were $73.2 million, compared with $93.0 million as of December 31, 2016​.  Full Article

Chiasma names Mark J. Fitzpatrick as CEO
Friday, 30 Sep 2016 

Chiasma Inc : Chiasma names Mark J. Fitzpatrick chief executive officer . Says CEO Mark Leuchtenberger resigned .Fitzpatrick currently serves as Chiasma's chief financial officer.  Full Article

Chiasma adopts a retention plan to provide cash retention payments to all remaining employees
Tuesday, 16 Aug 2016 

Chiasma Inc : Adopted a retention plan, effective immediately to provide cash retention payments to all remaining employees of co- sec filing . Retention payments are expected to be made in January 2017 Source: (http://bit.ly/2b1crqL) Further company coverage: [CHMA.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Chiasma announces workforce reduction
Tuesday, 16 Aug 2016 

Chiasma Inc : Chiasma announces workforce reduction . Continues to enroll patients in its mpowered phase 3 trial . Further reducing its workforce by approximately 44% . Will incur aggregate charges related to headcount reduction of about $0.8 million to $1.0 million for one-time severance and related costs in Q3 . Company expects to realize more than $7.0 million in annualized payroll and related expense savings as a result of restructuring actions . Chiasma Inc says expects to realize more than $7.0 million in annualized payroll and related expense savings as a result of these combined actions .Charges related to headcount reduction expected to result in cash expenditures that will be substantially complete by end of Q1 of 2017.  Full Article

Chiasma records restructuring charge of about $6.5 mln in Q2
Wednesday, 10 Aug 2016 

Chiasma Inc : Chiasma provides corporate update and reports second quarter 2016 results . Recorded a restructuring charge of approximately $6.5 million for quarter ended June 30, 2016 . Chiasma Inc qtrly basic loss per share $1.10 .Approximately $1.8 million of charge was attributable to restructuring plan that was announced in June 2016.  Full Article

BRIEF-Chiasma Announces FDA Agreement To Redefine Certain Secondary Endpoints In Phase 3 Clinical Trial

* CHIASMA ANNOUNCES FDA AGREEMENT TO REDEFINE CERTAIN SECONDARY ENDPOINTS IN CHIASMA OPTIMAL PHASE 3 CLINICAL TRIAL